Vortioxetine for Newly Diagnosed Glioblastoma
Clinical trial NCT07284628 · RECRUITING
Trial details
- NCT number
- NCT07284628
- Sponsor
- University of Zurich
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-24
- Primary completion
- 2029-06-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.